ExonHit Therapeutics this week launched its Human GW SpliceArray, a genome-wide splice variant detection tool that monitors more than 23,000 human genes covering 130,000 expressed transcripts and uses over 6 million probes to help study the human proteome.
ExonHit said the chip is built on the Affymetrix platform, and offers researchers the ability to interrogate both exons and splice junctions on a single microarray.